[1] Boyle P, Leon ME, Maisonneuve P, et al. Cancer control in women.Update 2003 [J]. Int J Gynaecol Obstet, 2003, 83 (Suppl 1):179-202. [2] Ugnat AM, Xie L, Morriss J, et al. Survival of women with breast cancer in Ottawa, Canada: variation with age, stage, histology, grade and treatment[J]. Br J Cancer, 2004, 90(6): 1138-43. [3] Linderholm B, Tavelin B, Grankvist K, et al. Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma[J]. J Clin Oncol, 1998, 16(9): 3121-8. [4] 中国抗癌协会编.新编常见恶性肿瘤诊治规范乳腺癌分册[M].北京医科大学中国协和医科大学联合出版社,1999.27-31. [5] 黄宗海,陈治,钱伟锋,等.血管内皮生长及其受体在大肠癌组织中的表达[J].第一军医大学学报,2001,21(3):206-8.Huang ZH, Chen Z, Qian WF, et al. Expression of vascular endothelial growth factor and its receptor in colorectal carcinoma [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2001, 21 (3):206-8. [6] Folkman J. What is the evidence that tumors are angiogenesis dependent[J]? J Natl Cancer Inst, 1990, 82(1): 4-6. [7] Iwasaka C, Tanaka K, Abe M, et al. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells [J]. J Cell Physiol, 1996, 169(3): 522-31. [8] Slevin M, Krupinski J, Slowik A, et al. Serial measurement of vascular endothelial growth factor and transforming growth factorbetal in serum of patients with acute ischemic stroke [J]. Stroke,2000, 31(8): 1863-70. [9] Ohta Y, Watanabe Y, Murakami S, et al. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer [J]. Br J Cancer, 1997, 76(8): 1041-5. [10] Jeltsch M, Kaipainen A, Joukov V, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice [J]. Science, 1997, 276 (5317):1423-5. [11] Leone A, Flatow U, VanHoutte K, et al. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line:effects on tumor metastatic potential, colonization and enzymatic activity[J]. Oncogene, 1993, 8(9): 2325-33. [12] 麦国丰,郑航,罗荣成,等.乳腺癌HER2、孕激素受体表达与生存期相关性的研究[J].第一军医大学学报,2003,23(4):372-4.Mai GF, Zheng H, Luo RC, et al. Association of progesterone receptor and HER2 expression with the survival time of patient with breast cancer [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue XueBao, 2003, 23(4): 372-4. [13] Sidoni A, Cavaliere A, Bellezza G, et al. Breast cancer in young women: clinicopathological features and biological specificity [J].Breast, 2003, 12(4): 247-50. [14] Shannon C, Smith IE. Breast cancer in adolescents and young women[J]. Eur J Cancer, 2003, 39(18): 2632-42. |